International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3)
Used principally in tumour or cancer registries for coding the site (topography) and the histology (morphology) of neoplasms, usually obtained from a pathology report.
A multi-axial classification of the site, morphology, behaviour, and grading of neoplasms.
The topography axis uses the ICD-10 classification of malignant neoplasms (except those categories which relate to secondary neoplasms and to specified morphological types of tumours) for all types of tumours, thereby providing greater site detail for non-malignant tumours than is provided in ICD-10. In contrast to ICD-10, the ICD-O includes topography for sites of haematopoietic and reticuloendothelial tumours.
The morphology axis provides five-digit codes ranging from M-8000/0 to M-9989/3. The first four digits indicate the specific histological term. The fifth digit after the slash (/) is the behaviour code, which indicates whether a tumour is malignant, benign, in situ, or uncertain (whether benign or malignant).
A separate one-digit code is also provided for histologic grading (differentiation).
Creation date: 1976
Last date change: 2000
Change description: Updates in nomenclature and Classification, with emphasis of changes on haematologic and neurologic neoplasms.
A single combined alphabetical index for topography and morphology.
Training and training materials:
The European Network of Cancer Registries has provided training courses with the assistance of the International Agency for Research on Cancer, the European Commission and the United States National Cancer Institute
Published: Chinese, Czech, English, Finnish, Flemish/Dutch, French German, Japanese, Korean, Portuguese, Spanish, Romanian, Turkish
Relationships with other classifications
Correspondence between revisions
Correspondence tables are available between ICD-O revisions and between ICD-O revisions and ICD-9 and ICD-10.
Correspondence with international, multinational, national classifications
The topography classification is essentially that used by ICD-10 for malignant tumours.
Relationships – conceptual, structural and other pertinent
Originally based on the American Cancer Society's Manual of Tumor Nomenclature and Coding (MOTNAC) first published in 1951.
Relationships with other terminologies
There is an agreement between the World Health Organization and the College of American Pathologists that the ICD-O morphology classification will be used for the M-8000 to M-9989 codes in the morphology axis of SNOMED. A change of SNOMED in 1993 led to incompatibilities for non-neoplastic lesions. For that reason ICD-O-3 does not longer include SNOMED codes for non-neoplastic lesions.
The Secretariat / WHO International Association of Cancer Registries c/o International Agency for Research on Cancer
150, cours Albert Thomas 69372 Lyon Cedex 08 France
Telephone: (33) 4 72 73 80 56; Fax: (33) 4 72 73 86 96 E-mail: email@example.com; firstname.lastname@example.org
Mr Freddie Bray
International Agency for Research on Cancer 150, cours Albert Thomas 69372 Lyon Cedex 08 France Telephone:(33) 4 72 73 80 56; Fax:Fax: (33) 4 72 73 86 96 E-mail: email@example.com
Dr Robert Jakob
World Health Organization 20 Av. Appia 1211 Geneva 27 Switzerland E-mail: firstname.lastname@example.org
Page updated on 5 October 2015